AstraZeneca to Cut 1,200 Jobs in Delaware - WBOC-TV 16, Delmarvas News Leader, FOX 21 -

AstraZeneca to Cut 1,200 Jobs in Delaware

Posted: Updated:

DOVER, Del. (AP/WBOC)- AstraZeneca PLC says it is cutting 1,200 jobs at its U.S. headquarters in Wilmington.

The pharmaceutical company said Monday that the cuts are part of a global restructuring of its research and development centers, to be completed by 2016. AstraZeneca said it is concentrating small molecule and biologics R&D activities in Gaithersburg, Md., as well as in England and Sweden.

AstraZeneca says the exit of it global medicines development group from Wilmington and the relocation of global marketing and U.S. specialty care commercial roles will result in about 1,200 job cuts in Wilmington. There will be a net increase of approximately 300 roles in Gaithersburg. The announced changes will lead to an estimated overall reduction of about 650 positions in the U.S. However, Wilmington will remain the company's North America commercial headquarters, with about 2,000 employees.

Gov. Jack Markell's office said it is not easy to hear that people will lose their jobs but that state officials understand the challenges AstraZeneca faces.

Powered by Frankly

All content © Copyright 2000 - 2017 WBOC. All Rights Reserved. For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices